Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Seminoma × Hearing × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Uterine Cervical Neoplasms 1 Testicular Neoplasms 1 Seminoma 1 Neoplasms 1 Hearing Loss 1 Adenocarcinoma 1

Interventions

sodium thiosulfate 1 Platinum 1 Magnetic Resonance Spectroscopy 1 Ipilimumab 1 Interleukin-12 Subunit p35 1 Hearing 1 Cisplatin 1 CTLA-4 Antigen 1 1,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07218913 2026-01-26

Testing the Addition of Pedmark to Cisplatin Chemotherapy for Reducing Drug-Induced Ear Damage in Men With Stage II-III Metastatic Testicular Germ Cell Tumors

City of Hope Medical Center

Phase 1 Recruiting

Testicular Neoplasms, Seminoma, Hearing Loss

Data powered by HemOnc (CC BY 4.0) Colophon ⚡